BNP Paribas Financial Markets
BNGO icon

BNP Paribas Financial Markets’s Bionano Genomics BNGO Stock Holding History

BNP Paribas Financial Markets’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15 Hold
13
– – ﹤0.01% 5760
2025
Q4 		$20 Hold
13
– – ﹤0.01% 5670
2025
Q3 		$22 Sell
13
-43
-77% -$137 ﹤0.01% 5498
2025
Q2 		$184 Buy
56
+43
+331% +$160 ﹤0.01% 5289
2025
Q1 		$36 Sell
13
-3
-19% -$20 ﹤0.01% 5301
2024
Q4 		$274 Buy
+16
New +$273 ﹤0.01% 5216
2023
Q3 		– Sell
-20
Closed -$7.36K – 3926
2023
Q2 		$7.36K Sell
20
-868
-98% -$392K ﹤0.01% 3652
2023
Q1 		$591K Buy
888
+73
+9% +$64.8K ﹤0.01% 2636
2022
Q4 		$714K Sell
815
-595
-42% -$749K ﹤0.01% 2372
2022
Q3 		$1.55M Sell
1,410
-68
-5% -$89.8K ﹤0.01% 2155
2022
Q2 		$1.22M Buy
1,478
+67
+5% +$68.9K ﹤0.01% 2067
2022
Q1 		$2.18M Buy
1,411
+961
+214% +$1.3M ﹤0.01% 1757
2021
Q4 		$807K Buy
450
+365
+429% +$976K ﹤0.01% 2734
2021
Q3 		$279K Buy
85
+67
+372% +$234K ﹤0.01% 2933
2021
Q2 		$79.4K Buy
+18
New +$71.1K ﹤0.01% 3107

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

BNP Paribas Financial Markets's BNGO Position: Q1 2026 in Review

BNP Paribas Financial Markets held its Bionano Genomics (BNGO) position steady in Q1 2026 at 13 shares worth $15. The position accounts for ﹤0.01% of the portfolio, ranked #5760.

BNP Paribas Financial Markets first reported a position in BNGO in Q2 2021 and has held it in 15 quarters since. The position peaked at $2.18M in Q1 2022. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.

  • BNP Paribas Financial Markets held 13 shares of Bionano Genomics worth $15 as of Q1 2026.
  • BNP Paribas Financial Markets left its Bionano Genomics share count unchanged in Q1 2026.
  • Bionano Genomics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5760 holding.
  • BNP Paribas Financial Markets first reported a position in Bionano Genomics in Q2 2021 and has held it in 15 quarters since.
  • BNP Paribas Financial Markets's Bionano Genomics position peaked at $2.18M in Q1 2022.
  • 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.